期刊
PLASTIC AND RECONSTRUCTIVE SURGERY
卷 143, 期 1, 页码 209E-220E出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/PRS.0000000000005102
关键词
-
类别
资金
- ACell Inc.
- Integra LifeSciences, Inc.
- Musculoskeletal Transplant Foundation
Background: Properly designed biodegradable scaffolds facilitate repair or regeneration of stromal tissues. Over the past 50 years, a variety of synthetic, semisynthetic, and decellularized scaffolds have been developed that provide surgeons with tools to reconstruct a wide array of structural defects. Methods: The authors review the literature of biological degradable scaffolds in current clinical use in the United States and highlight their design principles and products in common use. Results: Host tissues populate scaffolds with inflammatory cells, fibroblasts, blood vessels, nerves, and lymphatics. Cells lay down extracellular matrix macromolecules, whereas enzymes degrade the scaffold. Over time, the scaffold can be totally replaced by host tissues. Conclusions: The greatest use of scaffolds in plastic surgery is in skin replacement, breast reconstruction, abdominal wall reconstruction, and peripheral nerve repair. Other areas of importance are cartilage and bone replacement and support for lining replacements such as bowel, bladder, mucosa, and dura. The wide range of research being performed in this field is likely to provide surgeons with more choices and improved materials to repair and regenerate stromal structures.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据